Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1

Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1

Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1
Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1
Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1

Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1

Fmoc-Thr(tBu)-SerPsi(Me, Me)Pro-OH CAS NO.1440609-18-1

Fmoc-Thr(tBu)-SerΨ(Me,Me)Pro-OH (CAS 1440609-18-1) is a specialized protected peptide building block featuring threonine (Thr) with tert-butyl (tBu) side-chain protection and serine (Ser) with a ψ(Me,Me)Pro pseudo-proline modification. The Fmoc (9-fluorenylmethoxycarbonyl) group enables selective N-terminal deprotection in solid-phase peptide synthesis (SPPS), while the tBu moiety stabilizes the threonine hydroxyl group during synthesis. The ψ(Me,Me)Pro structure induces enhanced peptide rigidity, improving resistance to enzymatic degradation, making it ideal for pharmacologically active peptide design, including peptide drugs, diagnostic reagents, and bioconjugates. With high purity (≥95% by RP-HPLC) and excellent chemical stability, this compound ensures reliable performance in peptide synthesis workflows, supporting drug discovery, medicinal chemistry, and academic research.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Fmoc – Thr(tBu)-SerPsi(Me, Me)Pro – OH
CAS NO.
1440609 – 18 – 1
Appearance
White to off-white lyophilized powder
Molecular Formula
C₂₉H₃₈N₄O₁₀
Molecular Weight
602.63 g/mol
Amino Acid SequenceFmoc – Thr(tBu)-SerPsi(Me, Me)Pro – OH
Purity (RP-HPLC)
≥ 98.0%
Solubility
Soluble in aqueous buffers such as DMF (dimethylformamide), DMSO (dimethyl sulfoxide), and certain organic solvents. Specific solubility depends on the pH and concentration.
Endotoxin< 1.0 EU/mg
Biological Activity
Specific biological activity is highly dependent on the application. It can be used in peptide synthesis for the preparation of bioactive peptides. Activity evaluation should be carried out in relevant biological assays according to the intended use.
Storage Conditions
Store at – 20°C in a dry, dark place. Protect from light, moisture, and air oxidation.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Fmoc-Thr(tBu)-SerΨ(Me,Me)Pro-OH is a specialized protected amino acid derivative used in solid-phase peptide synthesis (SPPS) to introduce a threonine residue with a tert-butyl (tBu) side-chain protecting group and a serine residue with a ψ(Me,Me)Pro pseudo-proline modification. The Fmoc (9-fluorenylmethyloxycarbonyl) group protects the N-terminus, allowing selective deprotection under mild base conditions (e.g., piperidine) during synthesis.
The tBu group on threonine prevents side-chain hydroxyl participation in unwanted reactions, while the ψ(Me,Me)Pro (Cα-dimethylated proline-like structure) introduces conformational constraints that can increase peptide rigidity and improve resistance to proteolysis. This combination is especially useful in designing bioactive peptides and constrained peptidomimetics. The stepwise protection/deprotection strategy ensures precise control over sequence, stereochemistry, and final product purity.


2.PRODUCT INDICATIONS

Primary Synthetic Target:

Used as a building block in the synthesis of conformationally constrained peptides, cyclic peptides, and protease-resistant bioactive molecules.
Peptide Synthesis Applications:

Incorporation into peptides where threonine and proline-like structures are required to stabilize secondary structures (e.g., β-turns, helices).

Ideal for producing peptides with enhanced metabolic stability and improved pharmacokinetic profiles.
Research & Development Uses:

Preclinical studies of structure-activity relationships (SAR) for peptide drugs.

Design of peptide inhibitors, receptor ligands, and vaccine candidates.
Industrial Applications:

Manufacturing of therapeutic peptides, diagnostics, and functional biomaterials.


3.CLINICAL EFFICACY OF PRODUCT

Synthesis Efficiency:
High coupling yields (>95%) achieved in SPPS protocols using this protected fragment, minimizing deletion and truncation byproducts.
Purity & Quality:
RP-HPLC purity typically ≥95%, ensuring reliable downstream peptide quality.
Residual protecting-group levels below pharmacopoeial limits after global deprotection.
Stability:
Stable under recommended storage (−20 °C, dry, inert atmosphere); shelf life exceeds 24 months when sealed properly.
Scalability:
Successfully scaled from milligram to multi-gram batches for preclinical peptide candidate production.
Safety Profile:
Non-toxic under standard laboratory handling; follow standard PPE protocols due to organic solvent use during synthesis.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.


 relationships.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.